From these dysregulated maternal serum proteins, in silico analysis pointed to candidates, which may drive trophoblastic transcriptomic changes, and corroborated earlier findings on angiotensinogen/angiotensin II in driving hypertension indirectly through FLT1 up-regulation in addition to its direct effects (91, 274). The gene discussed is AGT; the disease is Hypertension.